Current filters:


1 to 9 of 12 results

Stability problems see Pfizer recall pain drug Embeda acquired in King deal


Within a couple of weeks of finally acquiring King Pharmacueticals for $3.6 billion, global drugs behemoth…

EmbedaKing PharmaceuticalsNeurologicalNorth AmericaPfizerPharmaceuticalRegulation

King updates on pain pipeline at APS


The USA's King Pharmaceuticals presented results from its expanded pain management portfolio at the American…

EmbedaKing PharmaceuticalsMorphine Sulfate and Naltrexone HydrochlorideniacinNiaspan

King's Embeda "effective for up to 12 months"


The USA's King Pharmaceuticals says that results from a Phase III study show that Embeda (morphine sulfate…

AvinzaEmbedaKing PharmaceuticalsMorphine SulfateMorphine Sulfate and Naltrexone HydrochloridenaltrexoneReviaRoxanol

FDA review of King's Embeda likely to extend into "early 2009"


King Pharmaceuticals says that the US Food and Drug Administration is continuing its review of the New…

EmbedaKing PharmaceuticalsMorphine Sulfate and Naltrexone HydrochloridenaltrexoneRevia

1 to 9 of 12 results

Back to top